WORCESTER, Mass., June 11, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced the presentation of clinical data at The Endocrine Society’s Annual Meeting (www.endo-society.org) being held in Washington, DC, June 10 - 13, 2009. The meeting focuses on the latest advances in endocrine research and clinical care.
